Publikationer

''Role of intravenous dosage regimens of bisphosphonates in relation to other aetiological factors in the development of osteonecrosis of the jaws in patients with myeloma''.

December 2015, Volume 53, Issue 10, Pages 1007–1011

 

''Så undviker du nekros i käkbenet''.

Tandläkartidningen, NR 7, 2015

 

''Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate''.

J Oral Maxillofac Surg. 2014 Jan;72(1):76-82. doi: 10.1016/j.joms.2013.06.221. Epub 2013 Aug 29.

 

''Evaluation of an algorithm ascertaining cases of osteonecrosis of the jaw in the Swedish National Patient Register''.

Clin Epidemiol. 2013;5:1-7. doi: 10.2147/CLEP.S37664. Epub 2013 Jan 4.

 

’’Lokalanestesi och smärta’’.

Studentlitteratur, 2008, ISBN 978-91-44-04820-8

 

“Käkledsartrit: infektions- och smärtrelaterade faktorer”

Temanummer, Tandläkartidningen, årg 100, nr 7, sid: 24-25, 2008

 

’’Läkemedel mot bennedbrytning kan ge käkbensnekros’’

Tandläkartidningen ÅRG 98 NR 14 2006

 

’’Bisfosfonater kan ge käkbensnekros – Patienter med malign skelettsjukdom i farozonen’’.

Läkartidningen nr 21–22 2006 volym 103

 

“Effects and distribution of the enamel matrix derivate Emdogain in the periodontal tissues of rat molars transplanted to the abdominal wall”.

Dental Traumatology 2002; 18: 12-23.

 

”Quantitative assessment of apoptotic and proliferative gingival keratinocytes in oral and sulcular epithelium in patients with gingivitis and periodontitis”.

J Clin Periodontol 2002:29: 1065-1071.

 

“Immunolocalization of interleukin-8 and proliferating cell nuclear antigen in gingival keratinocytes in patients with periodontitis”.

Acta Odontol Scand 2000;58:249-254.

 

 

 

 

 

 

 

 

Engelbrektsväg 50 C

19162 Sollentuna

 

Copyright 2016 Jarnbring Käkkirurgi AB